LUCAR-G79

· Nanjing Legend Biotech Co.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LUCAR-G79, covering 2025-12-04 to 2025-12-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LUCAR-G79 in Subjects With Relapsed/Refractory Autoimmune Diseases [Phase 1]